(Q36528827)

14 August 2017

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement (English)

1 reference

14 August 2017

1 reference

1 reference

Mones Abu-Asab

3

0 references

Markus Ries

object named as

Markus Ries

4

0 references

Martha Quezado

7

object named as

Martha Quezado

1 reference

14 August 2017

Raphael Schiffmann

1

1 reference

14 August 2017

Amy Rapkiewicz

2

1 reference

14 August 2017

Hasan Askari

5

1 reference

14 August 2017

Maria Tsokos

6

1 reference

14 August 2017

language of work or name

1 reference

29 November 2005

1 reference

14 August 2017

1 reference

14 August 2017

448

1 reference

14 August 2017

3

1 reference

14 August 2017

337-343

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-005-0089-x

14 August 2017

0 references

cites work

Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Cardiac manifestations in Fabry disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Involvement of dorsal root ganglia in Fabry's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Neuropathological and biochemical studies in Fabry's disease.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Effect of genetic modifiers on cerebral lesions in Fabry disease.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Sequelae of storage in Fabry disease--pathology and comparison with other lysosomal storage diseases

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288734

Fabry disease. A case report

21 September 2018

1 reference

12 December 2020

Case 2-1984: Fabry's disease

1 reference

12 December 2020

Fabry Disease: An Unusual Cause of Severe Coronary Disease in a Young Man

1 reference

12 December 2020

Angiokeratoma corporis diffusum universale (Fabry's disease): a case with gross myocardial involvement

1 reference

12 December 2020

Enzymatic Defect in Fabry's Disease

1 reference

12 December 2020

Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy

1 reference

12 December 2020

10.1007/S00428-005-0089-X

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16315019

1 reference